A defined isothiocyanate mixture suppresses platelet signaling and metabolism to limit thrombosis in vivo
Pathological platelet activation drives thrombosis and is a major contributor to morbidity and mortality. Current antiplatelet therapies reduce thrombotic risk but target a limited range of signaling pathways, have minimal impact on established platele…